Viewing Study NCT01618734


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2026-03-02 @ 7:43 AM
Study NCT ID: NCT01618734
Status: COMPLETED
Last Update Posted: 2012-06-13
First Post: 2012-06-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety.
Sponsor: Henri Mondor University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Immune Thrombocytopenia View
None Thrombopoietin Receptor Agonist View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immune Thrombocytopenia View
None Thrombopoietin receptor agonist View